Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Sees Significant Decrease in Short Interest

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 3,880 shares, a decline of 68.0% from the June 15th total of 12,119 shares. Based on an average trading volume of 24,174 shares, the short-interest ratio is currently 0.2 days. Currently, 1.0% of the company’s shares are sold short.

Defiance Daily Target 2X Long LMND ETF Stock Up 1.6%

Shares of NASDAQ LMNX traded up $0.29 during mid-day trading on Monday, reaching $18.88. 4,696 shares of the company’s stock were exchanged, compared to its average volume of 43,591. The firm has a market capitalization of $6.61 million, a price-to-earnings ratio of 37.02 and a beta of 9.31. The company has a current ratio of 8.37, a quick ratio of 6.08 and a debt-to-equity ratio of 0.52. The business has a fifty day simple moving average of $14.13 and a 200 day simple moving average of $21.33. Defiance Daily Target 2X Long LMND ETF has a twelve month low of $10.17 and a twelve month high of $55.00.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.